Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company focused on developing and commercializing medications for serious medical conditions, including responsible pain management and attention deficit hyperactivity disorder (ADHD). The company generates revenue through the sale of its differentiated pharmaceutical products. Collegium operates primarily in the United States and is headquartered in Stoughton, Massachusetts.
